Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest CHOP Stories

2014-03-12 23:24:38

Researchers say a combination of bendamustine and rituximab may be just as effective and less toxic than standard chemotherapy for indolent lymphomas. Raleigh, NC (PRWEB) March 12, 2014 According to the Non-Hodgkin’s Lymphoma Center, a study published in the journal Blood suggests that patients with certain kinds of Non-Hodgkin’s Lymphomas may get equally good results from a new chemotherapy combination than from the standard drugs. Researchers at the Sarah Cannon Research Institute...

2014-03-03 23:22:47

Researchers say reduced white blood cell count with chemotherapy could be corrected with appropriate medication. Raleigh, NC (PRWEB) March 03, 2014 Researchers examining the rates of grade 3 and 4 neutropenia, a side effect of chemotherapy, say patients who are younger than 65 are less likely to receive prophylactic treatment for the problem. Neutropenia is characterized by an abnormally low number of neutrophils, a type of circulating white blood cell that destroys bacteria in the blood....

2013-12-16 16:25:47

CHOP to receive $10,000 in life-giving support, largest amount ever PHILADELPHIA, Dec. 16, 2013 /PRNewswire/ -- WHEN: Thursday, December 19, 2013 at 10:30 a.m. WHERE: Robert Indiana's Love sculpture Love Park 1599 JFK Blvd., Philadelphia WHAT: Conestoga Bank will present a check for $10,000 to Children's Hospital of Philadelphia (CHOP), the proceeds...

2013-09-25 08:25:56

Hit producer CHOPS showcases international urban music with Kickstarter campaign PHILADELPHIA, Sept. 25, 2013 /PRNewswire/ -- CHOPS began making his mark as rapper and producer in the Mountain Brothers, the first Asian American rap group ever signed to a major label. They were recognized as cultural groundbreakers, having released 2 critically acclaimed albums with network video play. CHOPS went on to work with many of the industry's biggest and best rappers, including Kanye West,...

2013-04-19 08:25:38

- Trial will assess ability of CIVO(TM) to rapidly evaluate multiple drug candidates within a single tumor to predict treatment response - SEATTLE, April 19, 2013 /PRNewswire/ -- Presage Biosciences, a leader in precision oncology, today announced the initiation of a clinical trial and the first patient use of CIVO(TM), the company's precision oncology platform designed to improve treatment decisions for cancer patients. The single arm, non-therapeutic, observational study, being...

2013-02-15 16:23:14

CHOP-Sponsored Play Area Serves Families in Surrounding Community KING OF PRUSSIA, Pa., Feb. 15, 2013 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia (CHOP) today celebrated the opening of a children's play area at King of Prussia Mall with a ribbon cutting ceremony. The 1,200-square-foot CHOP-sponsored play area benefits local families, serving as a place for young children to play and exercise while at King of Prussia Mall. (Photo -...

2013-01-08 12:21:04

--A Portion of the Proceeds Will Support Community Programs-- PHILADELPHIA, Jan. 8, 2013 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia unveiled a CHOP specialty license plate followed by an auction of the first license plate during an event today in the Hospital's Colket Atrium. Serving as the auctioneer, CBS TV and WOGL's Bob Kelly sold 0001 to Children's Hospital Board of Trustee member Reid Buerger for $2500. (Photo:...

2012-12-17 04:21:51

SEATTLE, Dec. 17, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) today announced the publication of results from a preclinical study of Pixuvri(TM) (pixantrone) in the The Journal of Pharmacology and Experimental Therapeutics providing potential mechanisms for lower cardiotoxicity in patients treated with Pixuvri who received prior doxorubicin therapy. While CHOP-R is considered an effective therapy and is the standard of care in first line treatment of aggressive...

2012-11-30 08:22:08

REGINA, SK, Nov. 30, 2012 /PRNewswire/ - What was once believed impossible became a reality on November 16(th): micro sensor motes were successfully sent into a Canadian heavy oil reservoir through an injection well and retrieved via a production well. This exciting result is from a field trial conducted by the PI Innovation Centre - a joint venture of the Canadian Petroleum Technology Research Centre (PTRC) and its Dutch-based partner INCAS(3) - in collaboration with Canadian...

2012-01-09 08:14:00

-- Children's Hospital of Philadelphia Research Finds Common Characteristics Among These Teens Who are Likely to Drive PHILADELPHIA, Jan. 9, 2012 /PRNewswire-USNewswire/ -- In the first study to investigate driving as it relates to teens with a high-functioning autism disorder (HFASD), child development and teen driving experts at The Children's Hospital of Philadelphia's Center for Child Injury Prevention Studies found that two-thirds of teenagers with a high-functioning autism...